| Dr Michael Anthony Williams, MD | |
|
1604 Meadows Ln, Vidalia, GA 30474-8914 | |
| (912) 245-4179 | |
| (912) 403-3346 |
| Full Name | Dr Michael Anthony Williams |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 37 Years |
| Location | 1604 Meadows Ln, Vidalia, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376504647 | NPI | - | NPPES |
| 00600575C | Medicaid | GA | |
| 000600575F | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 38650 (Georgia) | Secondary |
| 208600000X | Surgery | 38650 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Candler County Hospital | Metter, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Authority Of Candler County | 5294623948 | 25 |
| Pineland Mhmrsa | 6002898616 | 8 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
A University of Arizona Cancer Center research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.
The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format.
› Verified 8 days ago
| Entity Name | Hospital Authority Of Candler County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588868947 PECOS PAC ID: 5294623948 Enrollment ID: O20040305000415 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
A University of Arizona Cancer Center research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.
The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format.
› Verified 8 days ago
| Entity Name | Pineland Mhmrsa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588735252 PECOS PAC ID: 6002898616 Enrollment ID: O20040607000175 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
A University of Arizona Cancer Center research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.
The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Anthony Williams, MD Po Box 648, Vidalia, GA 30475-0648 Ph: (912) 245-4179 | Dr Michael Anthony Williams, MD 1604 Meadows Ln, Vidalia, GA 30474-8914 Ph: (912) 245-4179 |
News Archive
Vaxonco Inc., a Korean company specializing in peptide-based vaccines and Ichor Medical Systems (Ichor), whose advanced TriGrid™ Delivery System (TriGrid™) is being tested worldwide for its ability to enhance delivery of DNA drugs and vaccines, announced today the initiation of a Phase I clinical trial to evaluate a novel DNA-based polyepitope vaccine against malaria.
A new study by researchers at Weill Cornell Medical College shows combining two already-FDA approved drugs may offer a new and potent punch against diseases in which blood vessel growth is abnormal - such as cancer, diabetic retinopathy, macular degeneration and rheumatoid arthritis.
A University of Arizona Cancer Center research team is engaged in a series of studies to investigate how genistein, a component of soy foods, might suppress the development of breast cancer.
The U.S. Food and Drug Administration is proposing to amend postmarket safety reporting regulations for three of its centers to require that manufacturers and other facilities subject to current reporting requirements submit their reports in an electronic format.
› Verified 8 days ago
Dr. Robert Bicknell Clark Jr., M.D.,F.A.C.S. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1811 Manning Dr, Vidalia, GA 30474 Phone: 912-537-6344 Fax: 912-537-1901 | |
Walter J Revell Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 305 W 1st St, Vidalia, GA 30474 Phone: 912-538-9080 Fax: 912-538-9085 | |
Dr. Kurt Patrick Hofmann, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1811 Edwina Dr, Vidalia, GA 30474 Phone: 912-538-9977 | |
Joy M Dunn, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1811 Edwina Dr, Vidalia, GA 30474 Phone: 912-538-9977 | |
Dr. Gregory Norkus, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1811 Edwina Dr, Vidalia, GA 30474 Phone: 912-538-9977 | |
Kendrix Jermaine Evans, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1811 Edwina Dr, Vidalia, GA 30474 Phone: 912-538-9977 Fax: 912-538-0770 | |
Dr. Henry Leon Ferland Iii, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1811 Edwina Dr, Vidalia, GA 30474 Phone: 912-538-9977 Fax: 912-538-0770 |